GÖRAN ANDO

BOARD MEMBER

Dr Göran Ando is Senior Advisor with EUSA Pharma’s lead shareholder, EW Healthcare Partners. Dr. Ando has over 35 years’ experience in the pharmaceutical industry, spent in a variety of senior international roles. He is the retired Chairman of Novo Nordisk, the world’s leading pharmaceutical company focused on diabetes. Previously, he was CEO of Celltech Group plc prior to its acquisition by UCB Pharma, and was Head of R&D at Pharmacia / Pharmacia & Upjohn. Dr Ando holds a Bachelor of Arts degree from Uppsala University in Sweden and a Medical Degree from Linkoeping University (Sweden).